发明名称 |
P38 MAP kinase inhibitors |
摘要 |
The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, including all stereoisomers, tautomers and isotopic derivatives thereof, which are inhibitors of p38 mitogen-activated protein kinase enzymes (referred to herein as p38 MAP kinase inhibitors), particularly the alpha and gamma kinase sub-types thereof, and their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD. |
申请公布号 |
AU2009326149(B2) |
申请公布日期 |
2014.01.16 |
申请号 |
AU20090326149 |
申请日期 |
2009.12.11 |
申请人 |
RESPIVERT LIMITED |
发明人 |
ITO, KAZUHIRO;STRONG, PETER;RAPEPORT, WILLIAM GARTH;MURRAY, PETER JOHN;KING-UNDERWOOD, JOHN;WILLIAMS, JONATHAN GARETH;ONIONS, STUART THOMAS;HIRST, SIMON CHRISTOPHER;TADDEI, DAVID MICHEL ADRIEN;CHARRON, CATHERINE ELISABETH |
分类号 |
C07D401/12;A61K31/415;A61P11/00;A61P29/00;C07D401/14 |
主分类号 |
C07D401/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|